Movement Alert｜Regeneron Pharmaceuticals Rises 3.05% in Regular Trading, Biotech Sector Rallies Broadly Ahead of Q2 Earnings

Market Focus

Jul 28

On July 28, Regeneron Pharmaceuticals rose 3.05% in regular trading, trading at 690.075 USD/share, with turnover of $98.52 million. The gain came amid a broad rally across the biotechnology sector, with peers including Amgen up 5.28%, AbbVie up 3.33%, Gilead Sciences up 3.29%, and Alnylam Pharmaceuticals up 2.8%, reflecting significant capital inflows into the sector.

Additionally, the company is scheduled to report second-quarter earnings on July 30 before the market opens, with consensus EPS expectations of $8.0. Market participants may be adjusting positions ahead of the report. Notably, the company previously disclosed in an SEC filing that it expects Q2 GAAP and non-GAAP diluted EPS to decrease by approximately $1, which could factor into investor expectations surrounding the release.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1145976951"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1145976951\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1145976951?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-28 22:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1145976951","market":"hk","top_or_hot":-1,"title":"Movement Alert｜Regeneron Pharmaceuticals Rises 3.05% in Regular Trading, Biotech Sector Rallies Broadly Ahead of Q2 Earnings","media":"Market Focus","content":"<p><p>On July 28, Regeneron Pharmaceuticals rose 3.05% in regular trading, trading at 690.075 USD/share, with turnover of $98.52 million. The gain came amid a broad rally across the biotechnology sector, with peers including Amgen up 5.28%, AbbVie up 3.33%, Gilead Sciences up 3.29%, and Alnylam Pharmaceuticals up 2.8%, reflecting significant capital inflows into the sector.</p><p>Additionally, the company is scheduled to report second-quarter earnings on July 30 before the market opens, with consensus EPS expectations of $8.0. Market participants may be adjusting positions ahead of the report. Notably, the company previously disclosed in an SEC filing that it expects Q2 GAAP and non-GAAP diluted EPS to decrease by approximately $1, which could factor into investor expectations surrounding the release.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Regeneron Pharmaceuticals Rises 3.05% in Regular Trading, Biotech Sector Rallies Broadly Ahead of Q2 Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Regeneron Pharmaceuticals Rises 3.05% in Regular Trading, Biotech Sector Rallies Broadly Ahead of Q2 Earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-28 22:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 28, Regeneron Pharmaceuticals rose 3.05% in regular trading, trading at 690.075 USD/share, with turnover of $98.52 million. The gain came amid a broad rally across the biotechnology sector, with peers including Amgen up 5.28%, AbbVie up 3.33%, Gilead Sciences up 3.29%, and Alnylam Pharmaceuticals up 2.8%, reflecting significant capital inflows into the sector.</p><p>Additionally, the company is scheduled to report second-quarter earnings on July 30 before the market opens, with consensus EPS expectations of $8.0. Market participants may be adjusting positions ahead of the report. Notably, the company previously disclosed in an SEC filing that it expects Q2 GAAP and non-GAAP diluted EPS to decrease by approximately $1, which could factor into investor expectations surrounding the release.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"REGN","symbol_name":"再生元制药公司","start_time":0,"source_url":"","article_id":"1145976951","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1145976951","pubTimestamp":1785249556,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 28, Regeneron Pharmaceuticals rose 3.05% in regular trading, trading at 690.075 USD/share, with turnover of $98.52 million. The gain came amid a broad rally across the biotechnology sector,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"REGN":"再生元制药公司"},"translate_title":"走势警报|再生元制药常规交易中上涨 3.05%，生物技术板块在第二季度收益公布前普遍上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"REGN":1},"content_text":"On July 28, Regeneron Pharmaceuticals rose 3.05% in regular trading, trading at 690.075 USD/share, with turnover of $98.52 million. The gain came amid a broad rally across the biotechnology sector, with peers including Amgen up 5.28%, AbbVie up 3.33%, Gilead Sciences up 3.29%, and Alnylam Pharmaceuticals up 2.8%, reflecting significant capital inflows into the sector.Additionally, the company is scheduled to report second-quarter earnings on July 30 before the market opens, with consensus EPS expectations of $8.0. Market participants may be adjusting positions ahead of the report. Notably, the company previously disclosed in an SEC filing that it expects Q2 GAAP and non-GAAP diluted EPS to decrease by approximately $1, which could factor into investor expectations surrounding the release.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}